ATI Physical Therapy (ATIP)
(Delayed Data from NYSE)
$6.17 USD
+0.08 (1.31%)
Updated Aug 13, 2024 03:59 PM ET
After-Market: $5.91 -0.26 (-4.21%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth A Momentum A VGM
ATI Physical Therapy, Inc. (ATIP) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$5.50 | $5.50 | $5.50 | -9.69% |
Price Target
Only one analyst offered a short-term price target of $5.50 for ATI Physical Therapy, Inc. This represents a decline of 9.69% from the last closing price of $6.09.
Analyst Price Targets (1 )
Broker Rating
ATI Physical Therapy, Inc. currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on two recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/28/2024 | The Benchmark Company | William Sutherland | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 2 |
Average Target Price | $5.50 |
LT Growth Rate | NA |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 43 of 253 |
Current Quarter EPS Est: | -3.12 |